<DOC>
	<DOCNO>NCT00195533</DOCNO>
	<brief_summary>The aim study compare efficacy tolerance piperacillin-tazobactam versus piperacillin-tazobactam plus glycopeptide initial empiric antibiotic treatment fever neutropenic patient . Study consecutive cohort ( 2 ) . First patient include monotherapy branch complete predict number case . When happen , Coordinating Center communicate participant center patient include combined therapy .</brief_summary>
	<brief_title>Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide Neutropenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<criteria>Patients hematological malignancy undergone stem cell transplantation neoplastic disease . Fever ( &gt; 38ÂºC ) Neutropenia ( absolute neutrophil count &lt; 500 &lt; 1000 anticipate fall 500 cell within 2448 hour ) . Known allergy antibiotic use trial A high probability death within 48 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Leukemia</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Myeloma</keyword>
</DOC>